ARDELYX, INC.·4

Jul 17, 4:09 PM ET

RAAB MICHAEL 4

4 · ARDELYX, INC. · Filed Jul 17, 2026

Research Summary

AI-generated summary of this filing

Updated

Ardelyx (ARDX) CEO Michael Raab Exercises Options, Sells Shares

What Happened

  • Michael Raab, President & CEO (and Director) of Ardelyx, exercised 20,834 option shares at $0.99 per share (total cost $20,626) on July 15, 2026, and sold 41,668 shares in an open-market transaction that generated $210,923 in proceeds. The filing also shows a derivative disposition of 20,834 shares at $0.00 (see Key Details for explanation).
  • The sale was executed under a pre-established 10b5-1 trading plan (see footnote). Sales are routine insider liquidity events and do not by themselves indicate company performance.

Key Details

  • Transaction date: July 15, 2026; Form 4 filed July 17, 2026 (timely filing).
  • Option exercise: 20,834 shares exercised at $0.99 each — total exercise cost reported $20,626.
  • Open-market sale: 41,668 shares sold, weighted-average sale price $5.06, proceeds $210,923. Trades occurred in a price range of $5.03–$5.12 (footnote F2).
  • Derivative disposition: 20,834 shares reported disposed at $0.00 (footnote indicates these shares are related to the option exercise/vesting mechanics).
  • Sale executed pursuant to a 10b5-1 trading plan adopted November 7, 2025 (F1).
  • Some shares are held in trusts (F3, F4). Option vesting schedule: options vest monthly in 48 equal installments beginning Jan 6, 2022, subject to continued service (F5).
  • Shares owned after the transactions: not specified in the information provided in this summary.

Context

  • The filing shows an exercise of options followed by an open-market sale of shares; when exercises and sales occur together, it can reflect a cashless or simultaneous exercise/sell to cover costs or realize proceeds. The Form 4 notes the transaction was completed under a 10b5-1 plan, which typically pre-specifies sales to avoid insider trading concerns.
  • This is a routine insider liquidity event for a named executive; factual details above should be considered alongside other company and insider ownership disclosures.

Insider Transaction Report

Form 4
Period: 2026-07-15
RAAB MICHAEL
DirectorPresident & CEO
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-07-15$0.99/sh+20,834$20,6261,720,034 total
  • Sale

    Common Stock

    [F1][F2]
    2026-07-15$5.06/sh41,668$210,9231,678,366 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F1][F5]
    2026-07-1520,834290,834 total
    Exercise: $0.99Exp: 2032-01-06Common Stock (20,834 underlying)
Holdings
  • Common Stock

    [F3]
    (indirect: By Trust)
    24,364
  • Common Stock

    [F4]
    (indirect: By Trust)
    1,000
Footnotes (5)
  • [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025.
  • [F2]Transaction was executed in multiple trades in prices ranging from $5.03 to $5.12, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  • [F3]The shares are directly held by Michael G. Raab, Trustee of the Michael G. Raab Living Trust dated July 25, 2012.
  • [F4]The shares are owned directly by trusts for the benefit of the Reporting Person's children.
  • [F5]The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
Signature
/s/ Felecia Ettenberg, Attorney-in-Fact for Michael Raab|2026-07-17

Documents

1 file
  • 4
    wk-form4_1784318944.xmlPrimary

    FORM 4